术中脑肿瘤压片细胞学与大块切除活检诊断准确性比较:卢旺达CHUK研究
该前瞻性横断面研究纳入77例影像学确诊的脑肿瘤手术患者,比较术中压片细胞学与最终组织病理学诊断的一致性。压片细胞学与组织病理学的一致率为89.6%,胶质瘤和脑膜瘤等主要肿瘤类型可被可靠识别,有助于及时的手术决策。结论认为术中压片细胞学是大块活检的快速可靠辅助手段,适用于资源有限环境。
要点
- 术中压片细胞学与最终组织病理学一致率达89.6%。
- 胶质瘤和脑膜瘤等主要肿瘤类型可被可靠识别。
- 压片细胞学有助于资源有限环境中的及时手术决策。
核心结论
- 术中压片细胞学是大块活检的快速可靠辅助手段,可改善资源有限环境下的脑肿瘤管理。
研究设计与样本
- 前瞻性横断面研究,纳入77例在卢旺达CHUK经影像学确认的脑肿瘤手术患者。
- 将压片细胞学诊断与最终组织病理学诊断进行比较以评估一致性。
主要发现
- 压片细胞学与组织病理学的一致率为89.6%。
- 胶质瘤和脑膜瘤等主要肿瘤类型可被可靠识别,有助于及时手术决策。
关键数值与推荐
- 压片细胞学与组织病理学一致率为89.6%。
临床怎么用
- 在资源有限环境中,可将术中压片细胞学作为大块活检的快速辅助手段用于脑肿瘤手术决策。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Accurate brain tumor diagnosis guides effective management, with large excision biopsy as the gold standard. Intra-operative cytologic smear techniques offer rapid analysis, particularly useful in resource-limited settings. The aim of this study was to evaluate the diagnostic accuracy and clinical utility of intra-operative cytologic smear techniques in brain tumor surgery at the University Teaching Hospital of Kigali (CHUK). OBJECTIVES: To evaluate the diagnostic accuracy and clinical utility of intra-operative cytologic smear compared to large excision biopsy in brain tumor surgery at CHUK. METHODS: A prospective cross-sectional study involving 77 patients with radiologically confirmed brain tumors undergoing surgery at CHUK. Squash cytology diagnoses were compared with final histopathology diagnoses for concordance. RESULTS: Squash cytology showed 89.6% agreement with histopathology. Major tumor types such as gliomas and meningiomas were reliably identified, facilitating timely surgical decisions. CONCLUSIONS: Intra-operative squash cytology is a rapid and reliable adjunct to large biopsy, improving brain tumor management in low-resource settings. Integration of advanced techniques could enhance diagnostic precision further.
引用
- Uwamariya D, Niyodusenga E, Surwumwe JB, et al. Accuracy of intra-operative brain tumor squash cytology compared to large excision biopsy: a comparative study at the University Teaching Hospital of Kigali (CHUK), Rwanda. J Neurooncol. 2025. PMID: 41359093. doi:10.1007/s11060-025-05344-y
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。